Home » Stocks » PBH

Prestige Consumer Healthcare Inc. (PBH)

Stock Price: $42.88 USD 0.38 (0.89%)
Updated Jan 27, 2021 10:17 AM EST - Market open
Market Cap 2.20B
Revenue (ttm) 959.60M
Net Income (ttm) 163.40M
Shares Out 50.33M
EPS (ttm) 3.21
PE Ratio 13.36
Forward PE 11.90
Dividend n/a
Dividend Yield n/a
Trading Day January 27
Last Price $42.88
Previous Close $42.50
Change ($) 0.38
Change (%) 0.89%
Day's Open 42.10
Day's Range 41.43 - 43.09
Day's Volume 112,210
52-Week Range 29.50 - 45.96

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 1 day ago

NEW YORK, Jan. 25, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Staar Surgical Co. (NASD: STAA) will replace Prestige ...

GlobeNewsWire - 2 weeks ago

TARRYTOWN, N.Y., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 third quarter earnings release on Thursday, F...

Forbes - 1 month ago

Markets sharply reversed during yesterday's trading session. However, the indices ended the day largely mixed.

Other stocks mentioned: AGX, GEF, MMC, PFE
Zacks Investment Research - 1 month ago

Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?

GuruFocus - 2 months ago

Growth-focused investors may want to consider the following small-cap stocks as they represent companies whose trailing 12-month pro forma earnings per share improved significantly on a year-o...

Other stocks mentioned: AMPH, GLDD
Seeking Alpha - 2 months ago

Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q2 2021 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Prestige Consumer's (PBH) second-quarter fiscal 2021 results reflect stable consumption for most brands and robust e-commerce growth. However, some brands see lower consumption amid the pandemic.

Zacks Investment Research - 2 months ago

Prestige Brands (PBH) delivered earnings and revenue surprises of 8.33% and 4.42%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 2 months ago

TARRYTOWN, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30,...

Zacks Investment Research - 2 months ago

Prestige Consumer's (PBH) second-quarter fiscal 2021 performance is likely to reflect soft consumption in certain categories. Nevertheless, robust cost curtailment efforts bode well.

GlobeNewsWire - 3 months ago

TARRYTOWN, N.Y., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 second quarter earnings release on Thursday, ...

Zacks Investment Research - 3 months ago

The rise in consumer spending comes despite a decline in personal income.

Other stocks mentioned: GO, LCUT, OLLI, SPB
Zacks Investment Research - 4 months ago

Prestige Consumer Healthcare (PBH) has been gaining from its focus on healthcare. Apart from this, the company's e-commerce investments and cost-management efforts look impressive.

Zacks Investment Research - 4 months ago

Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 5 months ago

With no signs of a vaccine yet, fears continue to haunt in spite of strict safety guidelines like social distancing and isolation, and a more cautious approach by people in general.

Other stocks mentioned: GO, OLLI, REYN, SPB
Seeking Alpha - 5 months ago

Prestige Brands Holdings (PBH) CEO Ron Lombardi on Q1 2021 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Prestige Consumer's (PBH) Q1 results gain from solid e-commerce performance and strong free cash flow amid the ongoing pandemic.

Zacks Investment Research - 5 months ago

Prestige Brands (PBH) delivered earnings and revenue surprises of 22.86% and 3.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 5 months ago

TARRYTOWN, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2020.

Zacks Investment Research - 5 months ago

Impacts of reversal in coronavirus-induced stockpiling trends are like to get reflected in Prestige Consumer's (PBH) first-quarter fiscal 2021 performance.

Zacks Investment Research - 5 months ago

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Forbes - 5 months ago

Major tech giants Amazon and Microsoft will be declaring their quarterly results later this week, and while estimates are reduced, expectations in the market are climbing. Our deep learning al...

Other stocks mentioned: CHTR, ERIE, ICE, VZ, VZA
GlobeNewsWire - 6 months ago

TARRYTOWN, N.Y., July 13, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 first quarter earnings release on Thursday,...

Zacks Investment Research - 7 months ago

Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 8 months ago

PBH vs. UNICY: Which Stock Is the Better Value Option?

Other stocks mentioned: UNICY
Zacks Investment Research - 8 months ago

Prestige Consumer Healthcare Inc. (PBH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Seeking Alpha - 8 months ago

Prestige Brands Holdings (PBH) CEO Ron Lombardi on Q4 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Prestige Consumer's (PBH) fourth-quarter fiscal 2020 results reflect solid consumption trends at core brands in the domestic regions and strong international unit performance.

Zacks Investment Research - 8 months ago

Prestige Brands (PBH) delivered earnings and revenue surprises of 10.81% and 4.48%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 8 months ago

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 11 months ago

As of late, it has definitely been a great time to be an investor in Prestige Consumer Healthcare.

Zacks Investment Research - 11 months ago

Prestige Consumer's (PBH) third-quarter fiscal 2020 results reflect strength in the International segment and robust consumption trends at core brands. However, retailer inventory reductions p...

Seeking Alpha - 11 months ago

Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 11 months ago

Prestige Brands (PBH) delivered earnings and revenue surprises of 8.00% and 0.42%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 11 months ago

Prestige Consumer's (PBH) third-quarter fiscal 2020 results are likely to reflect gains from the International unit. However, weakness in the North America unit and currency woes are concerning.

Zacks Investment Research - 1 year ago

A sturdy gross margin trend bodes well for Prestige Consumer (PBH). Also, the company is benefitting from robust cash position and focus on healthcare brands.

GlobeNewsWire - 1 year ago

TARRYTOWN, N.Y., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Pre...

GlobeNewsWire - 1 year ago

TARRYTOWN, N.Y., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Pre...

Seeking Alpha - 1 year ago

Prestige Consumer Healthcare's (PBH) CEO Ron Lombardi on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Prestige Consumer's (PBH) Q2 performance gains from strong consumption trends. However. inventory reductions were a drag.

Zacks Investment Research - 1 year ago

Prestige Brands (PBH) delivered earnings and revenue surprises of 4.62% and 0.39%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 1 year ago

TARRYTOWN, N.Y., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2020 second quarter earnings release on Thursday...

Zacks Investment Research - 1 year ago

Prestige Consumer (PBH) gains from a robust cash position and focus on healthcare brands.

Zacks Investment Research - 1 year ago

Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 1 year ago

Prestige Consumer (PBH) benefits from strong margin trends and solid cash flow. However, declining revenues are a concern.

Seeking Alpha - 1 year ago

Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Prestige Consumer (PBH) delivers better-than-expected fiscal Q1 results, driven by solid consumption trends. However, both earnings and sales fall year over year.

Zacks Investment Research - 1 year ago

Prestige Brands (PBH) delivered earnings and revenue surprises of 1.56% and 0.36%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Currency headwinds and lower inventory are likely to hurt Prestige Consumer's (PBH) first-quarter fiscal 2020 results.

About PBH

Prestige Consumer Healthcare, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral... [Read more...]

Industry
Medical Distribution
IPO Date
Feb 10, 2005
CEO
Ronald M. Lombardi
Employees
520
Stock Exchange
NYSE
Ticker Symbol
PBH
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for PBH stock is "Buy." The 12-month stock price forecast is 42.75, which is a decrease of -0.30% from the latest price.

Price Target
$42.75
(-0.30% downside)
Analyst Consensus: Buy